JAMA
Original Investigation
April 6, 2024
Richard M.ÌýMartin, BM, BS, PhD; Emma L.ÌýTurner, PhD; Grace J.ÌýYoung, MSc; Chris Metcalfe, PhD; Eleanor I.ÌýWalsh, MSc; J. Athene Lane, PhD; Jonathan A. C.ÌýSterne, PhD; Sian Noble, PhD; Peter Holding, MSc; Yoav Ben-Shlomo, MBBS, PhD; Naomi J.ÌýWilliams, PhD; Nora Pashayan, MD, PhD; Mai Ngoc Bui, PhD; Peter C.ÌýAlbertsen, MD; Tyler M.ÌýSeibert, MD, PhD; Anthony L.ÌýZietman, MD; Jon Oxley, MD; Jan Adolfsson, MD; Malcolm D.ÌýMason, MD; George Davey Smith, DSc; David E.ÌýNeal, MD; Freddie C.ÌýHamdy, MD; Jenny L.ÌýDonovan, PhD; CAP Trial Group
is active quiz
has multimedia
JAMA. 2024; 331(17):1460-1470. 10.1001/jama.2024.4011
This secondary analysis of a randomized clinical trial assesses whether screening for prostate-specific antigen reduces prostate cancer mortality at 15-year follow-up.
JAMA
Original Investigation
March 6, 2018
Richard M.ÌýMartin, PhD; Jenny L.ÌýDonovan, PhD; Emma L.ÌýTurner, PhD; Chris Metcalfe, PhD; Grace J.ÌýYoung, MSc; Eleanor I.ÌýWalsh, MSc; J. Athene Lane, PhD; Sian Noble, PhD; Steven E.ÌýOliver, PhD; Simon Evans, MD; Jonathan A. C.ÌýSterne, PhD; Peter Holding, MSc; Yoav Ben-Shlomo, PhD; Peter Brindle, MD; Naomi J.ÌýWilliams, PhD; Elizabeth M.ÌýHill, MSc; Siaw Yein Ng, PhD; Jessica Toole, MSc; Marta K.ÌýTazewell, MSc; Laura J.ÌýHughes, BA; Charlotte F.ÌýDavies, PhD; Joanna C.ÌýThorn, PhD; Elizabeth Down, MSc; George Davey Smith, DSc; David E.ÌýNeal, MD; Freddie C.ÌýHamdy, MD; CAP Trial Group
free access
JAMA. 2018; 319(9):883-895. 10.1001/jama.2018.0154
This cluster randomized trial evaluates the effect of a single prostate-specific antigen (PSA) screening test on 10-year prostate cancer–specific mortality among men aged 50 to 69 years treated at UK primary care practices.